Cardiac tissue stimulator providing P-wave verification, telemetry, marker channels, and antitachycardia capabilities

• US 4,559,947 A
• Filed: 01/27/1984
• Issued: 12/24/1985
• Est. Priority Date: 01/27/1984
• Status: Expired due to Term

• Current Assignee: Pacesetter AB
• Original Assignee: Siemens-Elema AB (Siemens AG)
• Inventors: Mann, Brian M., Renger, Herman L., Meador, John
• Primary Examiner(s): Kamm, William E.
• Application Number:
  US06/574,707
• Time in Patent Office: 697 Days
• Field of Search: 128/419 PG
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/37223 Circuits for electromagnetic coupling

Abstract

A programmable cardiac tissue stimulator having a receiving coil and RF pulse width check/data separator (6) for receiving programming data, a communications State sequencer (8) for directing the sequence of command activities within the apparatus, command decode and address latch (12), memory (16, 18, 20, 22, 30, 40, 42) for storing the received programming data, pulse generator logic (24) for generating an output stimulation pulse according to a programmed stimulation scheme, a first timer (32), a second timer (34) and third timer (44) interactive with the pulse generator (24) and memory (16, 18, 20, 22, 30, 40, 42) for carrying out the timing functions of the pulse generator logic (24), a first sensor (46) for sensing electrical activity in the atrium, a second sensor (48) for sensing electrical activity in the ventricle, antitachycardia logic (50) for limiting the rate of natural stimulation of cardiac tissue, an output lead (54) to the atrium, an output lead (56) to the ventricle, and a control clock (28) for controlling timing within the apparatus.

Claims

1. In a cardiac tissue stimulator that includes means for generating stimulation pulses that are delivered to cardiac tissue, and means for sensing electrical activity at or within said cardiac tissue, a means for determining whether sensed electrical activity from said cardiac tissue is verified electrical activity or noise, said means for determining including:

means for defining a first time period within which electrical activity may be sensed;

verification means for defining a verification period, said verification period being intitiated by the beginning of sensed electrical activity within said first time period;

signaling means for signaling, once said verification means is initiated, whether the sensed electrical activity lasts for a time period that is longer than said verification period, in which case the sensed electrical activity is considered to be verified electrical activity, or whether the sensed electrical activity lasts for a time period that is shorter than said verification period, in which case the sensed electrical activity is considered to be noise.

2. The cardiac tissue stimulator of claim 1 further including means for defining the sensed electrical activity to be verified electrical activity whenever the first time period times out before the verification period times out.

3. The cardiac tissue stimulator of claim 1 wherein the sensed electrical activity comprises the occurrence of a P-wave.

4. The cardiac tissue stimulator of claim 1 wherein said means for defining a first time period comprises a first timer circuit (B) that defines a basic pacing interval assocuated with the operation of said cardiac tissue stimulator, and wherein the first time period defined by said first timer circuit comprises the time period that said first timer circuit remains in a prescribed state.

5. The cardiac tissue stimulator of claim 4 wherein said verification means comprises a second timer circuit (A), coupled to said first timer circuit (B), and wherein said verification period comprises the time period that said second timer cirucit remains in a prescribed state.

6. The cardiac tissue stimulator of claim 5 wherein the occurrence of sensed electrical activity causes said second timer circuit (A) to change states from a first prescribed state (A0) to a second prescribed state (A1), and wherein said second timer circuit remains in said second prescribed state (A1) for the prescribed verification period.

7. The cardiac tissue stimulator of claim 6 wherein the prescribed verification period is selectable.

8. The cardiac tissue stimulator of claim 6 wherein the prescribed verification period assumes one of two selectable values, a standard verification period and a shortened verification period.

9. The cardiac tissue stimulator of claim 8 wherein the shortened verification period is automatically selected upon the occurrence of a prescribed state of said first timer circuit (B) in combination with the occurrence of prescribed signals.

10. The cardiac tissue stimulator of claim 6 wherein the prescribed verification period may be cut short by the occurrence of specified events within said cardiac tissue stimulator.

11. The cardiac tissue stimulator of claim 10 wherein the specified events that cut short the prescribed verification period include the sensing of additional specified electrical activity at the same time as the occurrence of a specified state of a third timer circuit (C), said third circuit (C) being coupled to said first timer circuit (B).

12. The cardiac tissue stimulator of claim 11 wherein the additional specified electrical activity comprises the sensing of an R-wave.

13. The cardiac tissue stimulator of claim 1 wherein said cardiac tissue stimulator is implanted beneath the skin of a user thereof.

14. The cardiac tissue stimulator of claim 13 further including telemetry means for allowing data to be selectively transferred to and from said cardiac tissue stimulator from a source external to the user thereof.

15. The cardiac tissue stimulator of claim 14 wherein the data telemetered from the implanted cardiac tissue stimulator includes two marker signals the indicate the status of specific events that take place within the heart of the user of the cardiac tissue stimulator as sensed by said cardiac tissue stimulator.

16. The cardiac tissue stimululator of claim 15 wherein the two marker signals are distinguished by their amplitude and duration.

17. The cardiac tissue stimulator of claim 16 wherein the duration of the two marker signals are dependent upon the states of a first timer circuit (B), a second timer circuit (A), and a third timer circuit (C), housed within said cardiac tissue stimulator.

18. A multi-mode, programmable, implantable cardiac tissue stimulator, said stimulator selectively providing operating modalities of at least DVI and DDD, and said stimulator including telemetry means for allowing data to be selectively transferred thereto and therefrom, said stimulator comprising:

atrial sensing means for sensing electrical activity in the atrium of a heart;

ventricular sensing means for sensing electrical activity in the ventricle of the heart;

pulse generating means for selectively supplying electrical stimulation pulses to the atrium and ventricle of the heart in response to timing control signals;

timing control signal generating means for generating said timing control signals, comprising;

a first timer (B) that defines a primary pacing interval during which a ventricular stimulation signal (TRV) and an atrial stimulation signal (TRA) are generated upon the occurrence of first and second specified events, respectively, said first and second specified events including the absence of verified sensed electrical activity by said ventricular sensing means and said atrial sensing means respectively, said TRV and TRA signals, if generated, being used by said pulse generating means to respectively trigger the stimulation pulses supplied to the ventricle and atrium,

a second timer (A) coupled to said first timer (B) that defines at least a first second-timer state (A1) and a second second-timer state (A2), the first second-timer state (A1) being initialized by the sensing of atrial electrical activity by said atrial sensing means concurrently with first specified conditions, said A1 state defining an A1 interval used to verify the sensing of the electrical activity in the atrium, and the second-timer state (A2) being initialized by the sensing of vertricular electrical activity by said ventricular sensing means concurrently with second specified conditions, said A2 state defining an interval A2 used to verify the sensing of electrical activity in the ventricle,

the primarry pacing interval defined by the first timer (B) not being affected by the initialization of the first state A1 of the second timer (A); and

marker channel means for signaling through said telemetry means the status of specific events that take place within the heart as sensed by said stimulator, said events including the generation of said TRA and TRV signals, as well as the inhibiting of said TRA and TRV signals as a result of verified sensed electrical activity by said atrial sensing means and said ventricular sensing means, respectively.

19. The stimulator of claim 18 wherein said marker channel means includes means for generating at least two distinguishable marker signals, said marker signals being used to modulate the signals transmitted through said telemetry means.

20. The stimulator of claim 19 wherein the marker signals are distinguished one from the other by their respective amplitudes.

21. The stimulator of claim 20 wherein one marker signal has an amplitude that is approximately 1/3 of the other marker signal.

22. The stimulator of claim 19 wherein the marker signals are distinguished one from the other by their respective durations.

23. The stimulator of claim 22 wherein the duration of the marker signals is set, at least in part, by said first and second timer circuits.

24. The stimulator of claim 23 wherein said marker signals are further distinguished one from the other by their respective amplitudes.

25. The stimulator of claim 18 wherein said telemetry means includes analog counter means for defining two discrete analog sequences, a first of said discrete analog sequences including a plurality of first sections, each of said first sections having specified data associated therewith that is telemetered through said telemetry means whenever its respective section is enabled by said analog counter means, and a second of said discrete analog sequences including a plurality of second sections, each of said second sections having specified data associated therewith that is likewise telemetered through said telemetry means whenever its respective section is enabled by the analog counter means.

26. The stimulator of claim 25 wherein said marker channel means includes means for generating a plurality of distinguishable marker signals when said analog counter means enables specified sections within said first discrete analog sequence and said second discrete analog sequence.

27. The stimulator of claim 26 wherein the first discrete analog sequence comprises sections 1-8, and the second discrete analog sequence defines sections 9-F, and wherein the specified section of the first discrete analog sequence within which said marker signals are generated comprise section 8, and wherein the specified sections of the second discrete analog sequence within which said marker signals are generated comprise sections 9, A, B, C, and D.

28. The stimulator of claim 25 wherein the stimulator paces asynchronously during said first of said discrete analog sequences, and wherein the specified data that is telemetered during the first of said discrete analog sequences includes internal measurements of the stimulator.

29. The stimulator of claim 18 further including means for breaking a tachycardia, the occurrence of said tachycardia being evidenced from the marker signals transmitted through said telemetry means.

30. The stimulator of claim 29 wherein said means for breaking the tachycardia comprises:

means for enabling an anti-tachycardia mode of operation;

means, operable during said anti-tachycardia mode of operation, for generating a stimulation pulse in response to a specified signal (TACIRIG), which stimulation pulse is delivered to a selected chamber of the heart; and

means for generating said specified signal (TACIRIG) in a sequence that breaks the tachycardia.

31. The stimulator of claim 30 wherein said selected chamber of the heart comprises the atrium.

32. The stimulator of claim 30 wherein said selected chamber of the heart comprises the ventricle.

33. The stimulator of claim 30 wherein said means for generating said stimulation pulse includes transmission means for transmitting an RF burst to the stimulator for a specified period of time after an off period of the stimulator.

34. The stimulator of claim 33 wherein said RF burst is 25 to 42 msec in duration and wherein there must be at least 8 msec of off period between bursts.

35. In an implanted cardiac tissue stimulator that includes means for generating stimulation pulses that are delivered to cardiac tissue within a heart, means for sensing depolarization of said cardiac tissue, and telemetry means for allowing data to be selectively transferred to and from the implanted cardiac tissue, a means for breaking a tachycardia that occurs within said cardiac tissue, said means for breaking tachycardia comprising:

switch means for enabling an anti-tachycardia mode of operation; and

anti-tach pulse generation means, operable during said anti-tachycardia mode of operation, for generating anti-tach stimulation pulses that are delivered to a selected chamber of the heart in a specified timing sequence.

36. The cardiac tissue stimulator of claim 35 wherein the generation of said anti-tach stimulation pulses are triggered by transmittng an RF burst of a specified duration to the stimulator through said telemetry means.

37. The cardiac tissue stimulator of claim 36 wherein the specified duration of said RF burst comprises 25 to 42 msec.

38. The cardiac tissue stimulator of claim 36 wherein a sequence of said RF bursts is transmitted to the stimulator at an RF burst rate, and wherein said stimulator includes means for disabling said anti-tachycardia mode of operation if the RF burst rate is equal to or greater than a basic stimulation rate associated with the cardiac tissue stimulator.

39. The cardiac tissue stimulator of claim 38 wherein at least 8 msec of off period exists between successive RF bursts.